8J4I

Unveiling the Role of Human Prohibitin 2 as a Mitochondrial Calcium Channel in Parkinson's Disease

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.35 mM [U-15N] [15N]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 850
2	2D 1H-15N HSQC	0.35 mM [U-15N] [15N]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 850
3	2D 1H-13C HSQC	0.35 mM [U-15N, U-13C] [15N, 13C]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 850
4	2D 1H-13C HSQC	0.35 mM [2H, 15N, IVL-13C] [2H, 15N, IVL-13C]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 850
5	3D HNCACB	0.35 mM [2H, 15N, 13C] [2H, 15N, 13C]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 600
6	3D HN(COCA)CB	0.35 mM [2H, 15N, 13C] [2H, 15N, 13C]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 600
7	3D HN(CO)CA	0.35 mM [2H, 15N, 13C] [2H, 15N, 13C]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 600
8	3D HNCA	0.35 mM [2H, 15N, 13C] [2H, 15N, 13C]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 600
9	3D HNCO	0.35 mM [2H, 15N, 13C] [2H, 15N, 13C]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 600
10	3D HN(CA)CO	0.35 mM [2H, 15N, 13C] [2H, 15N, 13C]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 600
11	3D HCCH-TOCSY	0.35 mM [U-15N, U-13C] [15N, 13C]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 850
12	3D CC(CO)NH	0.35 mM [U-15N, U-13C] [15N, 13C]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 850
13	3D H(CCO)NH	0.35 mM [U-15N, U-13C] [15N, 13C]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 850
14	3D 1H-15N NOESY	0.35 mM [U-15N] [15N]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 850
15	3D 1H-15N NOESY	0.35 mM [50%-2H, 15N, 13C] [50%-2H, 15N, 13C]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 850
16	3D 1H-15N NOESY	0.5 mM 50%[15N, 2H]-50%[15%C13] 50%[15N, 2H]-50%[15%C13]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 950
17	3D 1H-15N NOESY	0.35 mM [U-15N, U-13C] [15N, 13C]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 950
18	3D 1H-15N NOESY	0.5 mM 50%[15N, 13C]-50%[14N, 12C] 50%[15N, 13C]-50%[14N, 12C]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 950
19	3D 1H-13C NOESY	0.35 mM [U-15N, U-13C] [15N, 13C]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 950
20	3D 1H-13C NOESY	0.35 mM [50%-2H, 15N, 13C] [50%-2H, 15N, 13C]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 950
21	3D 1H-13C NOESY	0.5 mM 50%[15N, 13C]-50%[14N, 12C] 50%[15N, 13C]-50%[14N, 12C]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 950
22	3D 1H-13C NOESY	0.5 mM 50%[15N, 2H]-50%[15%C13] 50%[15N, 2H]-50%[15%C13]-hPHB2	90% H2O/10% D2O	50 mM	5.6	1 atm	308	Bruker AVANCE III 950

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	600
2	Bruker	AVANCE III	850
3	Bruker	AVANCE III	950

NMR Refinement
Method	Details	Software
simulated annealing		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	15
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	CcpNmr Analysis		CCPN
2	structure calculation	X-PLOR NIH		X-PLOR NIH
3	refinement	X-PLOR NIH		X-PLOR NIH
4	peak picking	CcpNmr Analysis		CCPN